Bulk Manufacturer of Controlled Substances Application: Johnson Matthey, Inc., 80159 [2020-27241]

Download as PDF 80159 Federal Register / Vol. 85, No. 239 / Friday, December 11, 2020 / Notices substance within this State . . . shall obtain a registration issued by the division in accordance with rules and regulations promulgated by it.’’). New Jersey statute defines ‘‘practitioner’’ as a ‘‘physician.’’ N.J. Stat. Ann. § 24:21–2 (West, current with laws through L. 2020, c. 109 and J.R. No. 2). It defines ‘‘physician’’ as ‘‘a physician authorized by law to practice medicine in this or any other state.’’ Id. Here, the weight of the evidence in the record is that Registrant’s license to practice medicine is currently suspended and that her CDS registration is inactive. In New Jersey, as already discussed, a ‘‘practitioner’’ must be a physician authorized by law to practice medicine. Id. As such, she is not a ‘‘physician’’ or a ‘‘practitioner’’ as New Jersey statute defines those terms. Id. Thus, since Registrant lacks authority to practice medicine in New Jersey and does not have an active New Jersey CDS registration, she is not eligible to dispense controlled substances in that state. N.J. Stat. Ann. § 24:21–11(c). As such, based on the overwhelming record evidence and the law in New Jersey, I find that Registrant is not authorized to dispense controlled substances in New Jersey. 21 U.S.C. 824(a)(3). Accordingly, I will order that Registrant’s DEA registration be revoked. Order Pursuant to 28 CFR 0.100(b) and the authority vested in me by 21 U.S.C. 824(a), I hereby revoke DEA Certificate of Registration No. FN5040136 issued to Anindita Nandi, M.D. This Order is effective January 11, 2021. In accordance with 21 CFR 1301.33(a), this is notice that on August 24, 2020, Sterling Pharma USA, LLC, 1001 Sheldon Drive, Suite 101, Cary, North Carolina 27513–2079, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: Controlled substance Tetrahydrocannabinols .. Drug code 7370 Schedule I The company plans to manufacture in bulk drug code 7370 (Tetrahydrocannabinols) exclusively from hemp extract, for distribution and sale to its customers. No other activities for this drug code is authorized for this registration. William T. McDermott, Assistant Administrator. [FR Doc. 2020–27240 Filed 12–10–20; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Timothy J. Shea, Acting Administrator. Drug Enforcement Administration [FR Doc. 2020–27235 Filed 12–10–20; 8:45 am] BILLING CODE 4410–09–P [Docket No. DEA–752] Drug Enforcement Administration Bulk Manufacturer of Controlled Substances Application: Johnson Matthey, Inc. [Docket No. DEA–748] AGENCY: DEPARTMENT OF JUSTICE Drug Enforcement Administration, Justice. ACTION: Notice of application. Bulk Manufacturer of Controlled Substances Application: Sterling Pharma USA, LLC Sterling Pharma USA, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and SUMMARY: VerDate Sep<11>2014 00:32 Dec 11, 2020 Jkt 253001 Johnson Matthey, Inc., has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before February 9, 2021. Such persons may also file a written request SUMMARY: Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: jbell on DSKJLSW7X2PROD with NOTICES applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before February 9, 2021. Such persons may also file a written request for a hearing on the application on or before February 9, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. PO 00000 Frm 00170 Fmt 4703 Sfmt 4703 for a hearing on the application on or before February 9, 2021. Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: In accordance with 21 CFR 1301.33(a), this is notice that on November 2, 2020, Johnson Matthey, Inc., 2003 Nolte Drive West Deptford, New Jersey 08066–1742, applied to be registered as an bulk manufacturer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: Controlled substance Gamma Hydroxybutyric Acid. Marihuana ...................... Tetrahydrocannabinols .. Dihyromorphine ............. Difenoxin ........................ Amphetamine ................ Methamphetamine ......... Lisdexamfetamine ......... Methylphenidate ............ Nabilone ........................ Norfentanyl .................... Cocaine ......................... Codeine ......................... Dihydrocodeine .............. Oxycodone .................... Hydromorphone ............. Diphenoxylate ................ Ecgonine ........................ Hydrocodone ................. Levorphanol ................... Meperidine ..................... Methadone ..................... Methadone intermediate Morphine ........................ Thebaine ........................ Opium tincture ............... Oxymorphone ................ Noroxymorphone ........... Alfentanil ........................ Remifentanil ................... Sufentanil ....................... Tapentadol ..................... Fentanyl ......................... Drug code Schedule 2010 I 7360 7370 9145 9168 1100 1105 1205 1724 7379 8366 9041 9050 9120 9143 9150 9170 9180 9193 9220 9230 9250 9254 9300 9333 9630 9652 9668 9737 9739 9740 9780 9801 I I I I II II II II II II II II II II II II II II II II II II II II II II II II II II II II The company plans to bulk manufacture the listed controlled substances for the internal use intermediates or for sale to its customers. In reference to drug codes 7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration. William T. McDermott, Assistant Administrator. [FR Doc. 2020–27241 Filed 12–10–20; 8:45 am] BILLING CODE 4410–09–P E:\FR\FM\11DEN1.SGM 11DEN1

Agencies

[Federal Register Volume 85, Number 239 (Friday, December 11, 2020)]
[Notices]
[Page 80159]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-27241]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-752]


Bulk Manufacturer of Controlled Substances Application: Johnson 
Matthey, Inc.

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Johnson Matthey, Inc., has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before February 9, 
2021. Such persons may also file a written request for a hearing on the 
application on or before February 9, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on November 2, 2020, Johnson Matthey, Inc., 2003 Nolte 
Drive West Deptford, New Jersey 08066-1742, applied to be registered as 
an bulk manufacturer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid..............     2010  I
Marihuana..............................     7360  I
Tetrahydrocannabinols..................     7370  I
Dihyromorphine.........................     9145  I
Difenoxin..............................     9168  I
Amphetamine............................     1100  II
Methamphetamine........................     1105  II
Lisdexamfetamine.......................     1205  II
Methylphenidate........................     1724  II
Nabilone...............................     7379  II
Norfentanyl............................     8366  II
Cocaine................................     9041  II
Codeine................................     9050  II
Dihydrocodeine.........................     9120  II
Oxycodone..............................     9143  II
Hydromorphone..........................     9150  II
Diphenoxylate..........................     9170  II
Ecgonine...............................     9180  II
Hydrocodone............................     9193  II
Levorphanol............................     9220  II
Meperidine.............................     9230  II
Methadone..............................     9250  II
Methadone intermediate.................     9254  II
Morphine...............................     9300  II
Thebaine...............................     9333  II
Opium tincture.........................     9630  II
Oxymorphone............................     9652  II
Noroxymorphone.........................     9668  II
Alfentanil.............................     9737  II
Remifentanil...........................     9739  II
Sufentanil.............................     9740  II
Tapentadol.............................     9780  II
Fentanyl...............................     9801  II
------------------------------------------------------------------------

    The company plans to bulk manufacture the listed controlled 
substances for the internal use intermediates or for sale to its 
customers. In reference to drug codes 7360 (Marihuana), and 7370 
(Tetrahydrocannabinols), the company plans to bulk manufacture these 
drugs as synthetic. No other activities for these drug codes are 
authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-27241 Filed 12-10-20; 8:45 am]
BILLING CODE 4410-09-P